Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.35772/ghm.2021.01010 http://scihub22266oqcxt.onion/10.35772/ghm.2021.01010 33688588!7936373!33688588     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Glob+Health+Med 2021 ; 3 (1): 1-5 Nephropedia Template TP {{tp|p=33688588|t=2021. COVID-19 vaccines: implementation, limitations and opportunities |pdf=|usr=}}{{33688588}} gab.com Text COVID-19 vaccines: implementation, limitations and opportunities JO: Glob Health Med http://www.kidney.de/pget.php?&tw=1&pmid=33688588 #FOAvip The speed of development and the magnitude of efficacy of recently developed vaccines directed against SARS-CoV-2 has been truly remarkable. This editorial will not summarize the highly publicized and reviewed information about the design and clinical trial results of these vaccines. Rather, I will speculate about several issues regarding i) considerations of the rollout and implementation of the multiple vaccines, ii) the use of the vaccines in ways different from those used in the registrational phase 3 studies, iii) the future both of SARS-CoV-2 in the human population and of "normal" human life returning after widespread vaccination, and iv) the implications of the success of these SARS-CoV-2 vaccines for vaccine development against other pathogens. Twit Text FOAVip COVID-19 vaccines: implementation, limitations and opportunities ????Glob Health Med http://www.kidney.de/pget.php?&tw=1&pmid=33688588 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33688588 #FOAvip English Wikipedia <ref>{{Cite pmid|33688588}}</ref> COVID-19 vaccines: implementation, limitations and opportunities #MMPMID33688588 Richman DD Glob Health Med 2021[Feb]; 3 (1): 1-5 PMID33688588show ga The speed of development and the magnitude of efficacy of recently developed vaccines directed against SARS-CoV-2 has been truly remarkable. This editorial will not summarize the highly publicized and reviewed information about the design and clinical trial results of these vaccines. Rather, I will speculate about several issues regarding i) considerations of the rollout and implementation of the multiple vaccines, ii) the use of the vaccines in ways different from those used in the registrational phase 3 studies, iii) the future both of SARS-CoV-2 in the human population and of "normal" human life returning after widespread vaccination, and iv) the implications of the success of these SARS-CoV-2 vaccines for vaccine development against other pathogens. äCOVID-19 vaccines: implementation, limitations and opportunities (epmc).pdf DeepDyve Pubget Overpricing